AC ACB Aurora Cannabis Inc. Common Shares Загрузка... : Бычьи и медвежьи мнения аналитиков

Aurora Cannabis is struggling as a standalone company: Canadian and Australian businesses are shrinking quarter after quarter, it has repeatedly disappointed earnings, and it has written off $6 billion of shareholder value, so the asset is better transferred to Curaleaf.

The author lists a large basket of tickers without any explicit position language or directional thesis, so all are indexed as watch.

Reports Aurora Cannabis reviewing a takeover bid from Curaleaf; no directional view.

Curaleaf announces a hostile takeover bid for Aurora at a 45% premium, which the author sees as bullish for cannabis consolidation and likely to trigger more deals.

The author agrees with the parent's sentiment that better performance from legacy LPs could attract more capital to the sector, but expresses no personal position.

The author lists a large basket of tickers without any position language or directional commentary, making this a watchlist rather than a trade idea.

1. THE FACT: Trump is considering reclassifying marijuana. 2. THE BRIDGE: Reclassifying marijuana, potentially to a less restrictive schedule, could significantly ease regulatory burdens, open up banking services, and expand market access for cannabis companies. This would be a major positive catalyst for the entire cannabis sector. 3. THE VERDICT: Potential marijuana reclassification is a strong positive catalyst for cannabis stocks.